IP Library Granted Patent US 11,077,421
Granted Patent B2
US 11,077,421 · App. 16/128,293 · Granted Aug 3, 2021

Carbon sorbent for removal of metal catalysts from pharmaceuticals

Inventors: Girish Srinivas (Broomfield, CO); Steven Dietz (Englewood, CO)
Assignee: TDA Research, Inc.
B01J20/20B01J20/28057B01J20/28061B01J20/28064B01J20/28066B01J20/28069B01J20/28071B01J20/28083B01J20/305B01J20/3078C01B32/30C07C67/34C07C67/56C07C201/12C07C201/16C07D209/42B01D15/00B01J2220/4825C01P2006/12C01P2006/14C01P2006/16C01P2006/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,077,421
App. No.
16/128,293
Granted
Aug 3, 2021
Kind
B2
Abstract

The present invention relates to a carbon sorbent the can selectively remove platinum-group metals and other heavy metals such as tin without co-removing organic synthesis products including pharmaceutical intermediates and finished Active Pharmaceutical Ingredients (APIs). The carbon sorbents of the present invention are made from low-cost, high purity starting materials and the resulting carbon sorbents are also very pure. The carbon sorbents possess a combination of certain nitrogen and phosphorous groups combined with mesoporosity (2 to 50 nm diameter pores) that proves the high metal adsorption.

Claims (11)

1. A carbon sorbent for removing metals from an active pharmaceutical ingredient (API) organic reaction product, the carbon sorbent comprising:

(a) a nitrogen content of at least 3 weight %, which is present in the form of pyridine, pyridone, pyrrole or N—P bonds;

(b) an oxygen content of between 7 weight % and 16 weight %;

(c) a phosphorous content of at least 0.8 atom % as measured by X-ray photoelectron spectroscopy;

(d) a BET surface area of between 200 and 1700 meters squared per gram;

(e) a mesopore volume of at least 0.05 cubic centimeters per gram, wherein mesopores have a diameter of from 2 to 50 nanometers;

(f) a platinum-group metal uptake of at least 83% from a solution of 1.3 ppm platinum-group metal in an organic solvent with an active pharmaceutical ingredient (API) organic reaction product present in the organic solvent at a concentration of 1.0 grams of the active pharmaceutical ingredient (API) organic reaction product per 0.5 grams of the carbon sorbent, and wherein less than 1% of the active pharmaceutical ingredient (API) organic reaction product is adsorbed by the carbon sorbent from the organic solvent simultaneously with the platinum-group metal uptake;

wherein the platinum-group metal is-palladium; and,

(g) a pH of at most 3.1.

2. The carbon sorbent of claim 1 , further comprising: an ash content of at most 1.0 weight %.

3. The carbon sorbent of claim 2 , further comprising: less than 0.1 atom % Na and less than 0.1 atom % K as measured by X-ray photoelectron spectroscopy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2022
From: SRINIVAS, GIRISH; DIETZ, STEVEN
To: TDA RESEARCH, INC.
Reel/Frame 060339/0710 →
Continuity (2)
Provisional Application 62314272 · Mar 28, 2016
Related Publication 20190099737A1 · Apr 4, 2019
Cited By (3)
US 12,440,822 US 12,440,826 US 12,636,632